Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-31

FDA Approved: PHENTERMINE — Supplemental Application (Aurolife Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for phentermine hydrochloride (phentermine) from Aurolife Pharma, LLC, under ANDA204318, authorizing continued marketing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine (Phentermine)

Snippet

SUPPL AP for PHENTERMINE (PHENTERMINE HYDROCHLORIDE)